Zacks: National Research Co. (NRCIA) Given Consensus Recommendation of “Hold” by Brokerages

National Research Co. (NASDAQ:NRCIA) has been assigned a consensus broker rating score of 3.00 (Hold) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold rating.

Zacks has also given National Research an industry rank of 69 out of 265 based on the ratings given to its competitors.

NRCIA has been the topic of a number of recent analyst reports. BidaskClub cut shares of National Research from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Zacks Investment Research cut shares of National Research from a “hold” rating to a “strong sell” rating in a research note on Friday, November 10th.

National Research (NRCIA) traded up $0.40 during midday trading on Wednesday, reaching $36.85. 15,683 shares of the company’s stock were exchanged, compared to its average volume of 29,675. National Research has a 12 month low of $16.50 and a 12 month high of $41.99. The company has a market cap of $971.18, a PE ratio of 41.88 and a beta of 1.56.

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 12th. Stockholders of record on Friday, December 29th were given a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 1.09%. The ex-dividend date of this dividend was Thursday, December 28th. National Research’s payout ratio is currently 45.45%.

In other news, major shareholder K/I/E/Trust Under Agreement 3/ sold 109,000 shares of National Research stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $37.00, for a total transaction of $4,033,000.00. Following the sale, the insider now owns 5,656,900 shares in the company, valued at $209,305,300. The transaction was disclosed in a document filed with the SEC, which is available at this link. In the last quarter, insiders have sold 134,715 shares of company stock worth $4,996,670. Company insiders own 37.54% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in the company. Schwab Charles Investment Management Inc. raised its position in shares of National Research by 0.6% during the second quarter. Schwab Charles Investment Management Inc. now owns 30,453 shares of the business services provider’s stock valued at $820,000 after buying an additional 190 shares during the last quarter. Neuberger Berman Group LLC raised its position in shares of National Research by 0.9% during the second quarter. Neuberger Berman Group LLC now owns 58,637 shares of the business services provider’s stock valued at $1,577,000 after buying an additional 545 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of National Research by 5.1% during the second quarter. Alliancebernstein L.P. now owns 12,369 shares of the business services provider’s stock valued at $333,000 after buying an additional 600 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of National Research by 75.2% during the third quarter. Wells Fargo & Company MN now owns 9,450 shares of the business services provider’s stock valued at $356,000 after buying an additional 4,056 shares during the last quarter. Finally, Citigroup Inc. raised its position in shares of National Research by 120.2% during the second quarter. Citigroup Inc. now owns 8,299 shares of the business services provider’s stock valued at $224,000 after buying an additional 4,531 shares during the last quarter. Hedge funds and other institutional investors own 24.90% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://www.thelincolnianonline.com/2018/01/13/zacks-national-research-co-nrcia-given-consensus-recommendation-of-hold-by-brokerages.html.

National Research Company Profile

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Get a free copy of the Zacks research report on National Research (NRCIA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply